BRIACELL THERAPEUTICS CORP. Payments Of Lease Liabilities Classified As Financing Activities
BRIACELL THERAPEUTICS CORP. (BCTX) reported Payments Of Lease Liabilities Classified As Financing Activities of $16.00 thousand for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Cash Flow › Financing Activities
ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities · last filed 2022-06-13
- BRIACELL THERAPEUTICS CORP. payments of lease liabilities classified as financing activities for the quarter ending 2022-04-30 was $7.40K.
| Period end | Payments Of Lease Liabilities Classified As Financing Activities 3 month | Payments Of Lease Liabilities Classified As Financing Activities 6 month | Payments Of Lease Liabilities Classified As Financing Activities 9 month |
|---|---|---|---|
| 2022-04-30 | $7.40K derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | $16.00K 6-K · filed 2022-06-13 | |
| 2022-01-31 | $8.60K 6-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |